IT1194117B - Derivati salicilici di n-acetilcisteina - Google Patents
Derivati salicilici di n-acetilcisteinaInfo
- Publication number
- IT1194117B IT1194117B IT25198/81A IT2519881A IT1194117B IT 1194117 B IT1194117 B IT 1194117B IT 25198/81 A IT25198/81 A IT 25198/81A IT 2519881 A IT2519881 A IT 2519881A IT 1194117 B IT1194117 B IT 1194117B
- Authority
- IT
- Italy
- Prior art keywords
- acetylcysteine
- acid
- acetylcistein
- reaction
- acetylsalicylic acid
- Prior art date
Links
- JZWFDVDETGFGFC-UHFFFAOYSA-N salacetamide Chemical class CC(=O)NC(=O)C1=CC=CC=C1O JZWFDVDETGFGFC-UHFFFAOYSA-N 0.000 title 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 abstract 2
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 abstract 2
- 229960004308 acetylcysteine Drugs 0.000 abstract 2
- 229960001138 acetylsalicylic acid Drugs 0.000 abstract 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 abstract 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 abstract 1
- 150000008064 anhydrides Chemical class 0.000 abstract 1
- 230000001760 anti-analgesic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000001754 anti-pyretic effect Effects 0.000 abstract 1
- 239000002221 antipyretic Substances 0.000 abstract 1
- 239000012736 aqueous medium Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 abstract 1
- 230000000510 mucolytic effect Effects 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 abstract 1
- 229960004889 salicylic acid Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 150000007970 thio esters Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
- C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT25198/81A IT1194117B (it) | 1981-11-20 | 1981-11-20 | Derivati salicilici di n-acetilcisteina |
| DE8282201443T DE3262569D1 (en) | 1981-11-20 | 1982-11-12 | Salicylic derivatives of n-acetylcysteine |
| AT82201443T ATE12102T1 (de) | 1981-11-20 | 1982-11-12 | Salicylderivate von n-acetyl-cystein. |
| EP82201443A EP0080229B1 (en) | 1981-11-20 | 1982-11-12 | Salicylic derivatives of n-acetylcysteine |
| US06/442,044 US4567163A (en) | 1981-11-20 | 1982-11-16 | Salicyclic acid derivatives of N-acetylcysteine and pharmacological use thereof |
| CA000415702A CA1202618A (en) | 1981-11-20 | 1982-11-16 | Salicylic derivatives of n-acetyl-cysteine |
| ES517540A ES8402258A1 (es) | 1981-11-20 | 1982-11-19 | Derivados salicilicos de n-acetilcisteina. |
| KR8205229A KR890000618B1 (ko) | 1981-11-20 | 1982-11-19 | N-아세틸시스테인의 살리실산 유도체의 제조방법 |
| JP57204423A JPS58146560A (ja) | 1981-11-20 | 1982-11-20 | Ｎ―アセチルシステインのサリチル誘導体及びその製造方法並びにこの誘導体を用いた薬剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT25198/81A IT1194117B (it) | 1981-11-20 | 1981-11-20 | Derivati salicilici di n-acetilcisteina |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IT8125198A0 IT8125198A0 (it) | 1981-11-20 |
| IT1194117B true IT1194117B (it) | 1988-09-14 |
Family
ID=11215991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT25198/81A IT1194117B (it) | 1981-11-20 | 1981-11-20 | Derivati salicilici di n-acetilcisteina |
Country Status (9)
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU574360B2 (en) * | 1983-05-13 | 1988-07-07 | Reichert, D. | Antisnoring agent |
| IT1206515B (it) * | 1983-08-09 | 1989-04-27 | Guidotti & C Spa Labor | N-acetilcisteina ederivati 2',4's-carbossimetilcisteina ad-difluoro-4-idrossi-(1,1'-bifenil)attivita' antinfiammatoria, 3-carbossilici della mucolitica, procedimento per laloro preparazione e relative composizioni farmaceutiche. |
| IT1194474B (it) * | 1983-11-23 | 1988-09-22 | Magis Farmaceutici | Derivati della cisteina,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono |
| WO1995000136A1 (en) * | 1993-06-18 | 1995-01-05 | Arcturus Pharmaceutical Corporation | Method for treating hyperkeratosis and diseases mediated by proteases |
| US5637616A (en) * | 1993-06-18 | 1997-06-10 | Arcturus Pharmaceutical Corporation | Method for treating diseases mediated by proteases |
| AU2825295A (en) * | 1994-06-13 | 1996-01-05 | Arcturus Pharmaceutical Corporation | Method for the treatment, prevention or minimization of hair loss |
| GB2320431B (en) * | 1996-12-20 | 2000-08-30 | Johnson & Johnson Medical | Compositions for the treatment of chronic wounds |
| CA2724023C (en) * | 2008-05-13 | 2014-02-18 | Genmedica Therapeutics Sl | Salicylate conjugates useful for treating metabolic disorders |
| US20100239552A1 (en) * | 2009-03-16 | 2010-09-23 | Genmedica Therapeutics Sl | Combination Therapies for Treating Metabolic Disorders |
| EP2408443A1 (en) | 2009-03-16 | 2012-01-25 | Genmedica Therapeutics SL | Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders |
| US8466197B2 (en) | 2010-12-14 | 2013-06-18 | Genmedica Therapeutics Sl | Thiocarbonates as anti-inflammatory and antioxidant compounds useful for treating metabolic disorders |
| WO2013037984A1 (en) | 2011-09-16 | 2013-03-21 | Genmedica Therapeutics Sl | Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders |
| KR20140084032A (ko) | 2011-09-16 | 2014-07-04 | 헨메디까 쎄라뻬우틱스 에세엘레 | 대사 장애를 치료하는데 유용한 항염증제와 항산화제 컨쥬게이트를 포함하는 약제학적 병용물 |
| US9630937B2 (en) | 2013-11-08 | 2017-04-25 | Promentis Pharmaceuticals, Inc. | Substituted N-acetyl-L-cysteine derivatives and related compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR4619M (US08066781-20111129-C00013.png) * | 1965-02-01 | 1966-11-28 | ||
| US4268456A (en) * | 1979-09-24 | 1981-05-19 | Ppg Industries, Inc. | Process for preparing chlorothiolformates |
-
1981
- 1981-11-20 IT IT25198/81A patent/IT1194117B/it active
-
1982
- 1982-11-12 AT AT82201443T patent/ATE12102T1/de not_active IP Right Cessation
- 1982-11-12 EP EP82201443A patent/EP0080229B1/en not_active Expired
- 1982-11-12 DE DE8282201443T patent/DE3262569D1/de not_active Expired
- 1982-11-16 CA CA000415702A patent/CA1202618A/en not_active Expired
- 1982-11-16 US US06/442,044 patent/US4567163A/en not_active Expired - Lifetime
- 1982-11-19 KR KR8205229A patent/KR890000618B1/ko not_active IP Right Cessation
- 1982-11-19 ES ES517540A patent/ES8402258A1/es not_active Expired
- 1982-11-20 JP JP57204423A patent/JPS58146560A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| US4567163A (en) | 1986-01-28 |
| ES517540A0 (es) | 1984-01-16 |
| CA1202618A (en) | 1986-04-01 |
| IT8125198A0 (it) | 1981-11-20 |
| JPS58146560A (ja) | 1983-09-01 |
| JPH059424B2 (US08066781-20111129-C00013.png) | 1993-02-04 |
| ATE12102T1 (de) | 1985-03-15 |
| DE3262569D1 (en) | 1985-04-18 |
| ES8402258A1 (es) | 1984-01-16 |
| KR890000618B1 (ko) | 1989-03-22 |
| EP0080229A1 (en) | 1983-06-01 |
| EP0080229B1 (en) | 1985-03-13 |
| KR840002350A (ko) | 1984-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT1194117B (it) | Derivati salicilici di n-acetilcisteina | |
| ATE168373T1 (de) | Benzofuranyl- und thiophenylalkancarbonsäurederivate | |
| CH512480A (fr) | Composition de matières organiques stabilisées contre la dégradation par l'oxygène, la chaleur et la lumière | |
| SE8005890L (sv) | Salter av (+)-katekin, deras framstellning och anvendning, och kompositioner innehallande dessa salter | |
| ES2126355T3 (es) | Procedimiento para la preparacion de creatina o monohidrato de creatina. | |
| MX9200396A (es) | Derivados de benciloxifenilo, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
| NO308607B1 (no) | Kjemisk forbindelse, et farmasøytisk preparat inneholdende denne, samt anvendelse av forbindelsen til fremstilling av en blodplateaggregeringsinhibiotor og fremstilling av et farmasøytisk preparat til behandling eller forebygging av trombotiske | |
| SE8206984L (sv) | Terapeutiskt medel | |
| SE8005714L (sv) | Acetoximetyl-penamforeningar anvendbara som beta-laktamasinnibitorer | |
| SE7609495L (sv) | N-tetrahydrofurfuryl-noroximorfon, dess syraadditionssalter, lekemedel innehallande dessa samt forfarande for framstellning derav | |
| JPS5350141A (en) | Stabilization of prostaglandin and prostaglandin analogues | |
| DK164176A (da) | Carboxylsyreamider, fremgangsmade til deres fremstilling samt deres anvendelse som legemidler | |
| DE3785104D1 (de) | Pharmazeutisch nuetzliche thiazolidin-4-karbonsaeure-derivate. | |
| SE8302689D0 (sv) | Pharmaceutical compositions containing more active ingredients | |
| ATE35811T1 (de) | Derivat der acetylsalicylsaeure, seine herstellung und dieses enthaltende pharmazeutische kompositionen. | |
| JPS5340779A (en) | Optically active tolpertisone, their preparation and pharmaceuticals containting the same | |
| ES534958A0 (es) | Procedimiento de preparar derivados cisteinicos | |
| CH512481A (fr) | Composition de matières organiques stabilisées contre la dégradation par l'oxygène, la chaleur et la lumière | |
| BE830880A (fr) | Derives de la benzoyl n',n'-di(n-propyl)-dl-isoglutamine posedant une activite antiarthrosique et anti-inflammatoire | |
| JPS5323916A (en) | Preparation of thioglycosides | |
| BE831683A (fr) | Acide 2,4,6-triiodo-5-methoxyacetamido-n-methylisophtalamique, ainsi que sels; ses halogenures d'acyle et ses esters | |
| JPS5299994A (en) | Stabilization of aqueous solution of basic aluminum salt | |
| Sampat et al. | Sodium Diethyldithiocarbamate as an Inhibitor for the Corrosion of Aluminum in Trichloroacetic Acid | |
| MX3084E (es) | Procedimiento para la obtencion de 2 - imino - 3 - ( 2 - cloro - 2 - fenil - etil ) tiazo lidina | |
| FR2044356A5 (en) | 2-phenyl propionyl salicylic acid and salts - analgesics and antipyretics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19971127 |